Discontinuing epidermal growth factor receptor-tyrosine kinase inhibitor during second-line chemotherapy: is the evidence strong enough?Wenhua Liang,Qihua He,Ying Chen,Xusen Zou, Lindsey Hamblin,Jianxing HeANNALS OF TRANSLATIONAL MEDICINE（2015）引用 1|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
